Akamis Bio Raises $60 Million for Cancer Gene Therapy, Signs Licensing Deal with Xuanzhu Biopharma
The company is launching a Phase Ib study that will test its first gene therapy in patients with locally advanced rectal cancer.
Related Articles
‘Deep Research’ shows how Google can win the AI race
I took Google’s new Gemini research agent for a spin and came away very impressed.
What happens when the internet disappears?
Huge swaths of the web are vanishing. What does that do to our culture?
When AI Systems Talk Amongst Themselves
When computers have multi-sensory conversations, will humans matter anymore?
Gene and Cell Therapies Take Aim at Parkinson’s Disease
New therapies that are less intrusive but more lasting than current interventions promise to arrest and even reverse neurodegeneration.
Overcoming the Plague of Counterfeit Medications
Measures to prevent counterfeiting include tamper-resistant labels, reengineered QR code systems, and track-and-trace legislation.
Will 2025 Be a “Technology Wake-Up Call” for Clinicians?
Large language models are transforming medicine with advanced diagnostic reasoning and AI/human collaboration.
C-LTMRs evoke wet dog shakes via the spinoparabrachial pathway
Many hairy mammals perform rapid oscillations of their body, called wet dog shakes, to remove water and irritants from their back hairy skin. The somatosensory…
California’s sees large population increase in 2024 – nearly returning to pre-pandemic level
The Vintage 2024 population estimates released by the U.S. Census Bureau this week show California’s population on July 1, 2024 was 39,431,000, an increase of…
Intermittent Fasting in Mice Slows Hair Regeneration, Triggers Apoptosis in Hair Follicle Stem Cells
Researchers said they don’t want to scare people away from practicing intermittent fasting as it is associated with a lot of beneficial effects.
Astronomers stunned by six-planet system frozen in time
Undisturbed family of “sub-Neptunes” in rhythmic orbits could hold clues to planet formation
